Esperion Therapeutics Inc.宣布与Anda Filer和DR. Reddy's Laboratories达成和解协议。根据协议条款,这两家公司承诺在2040年4月19日之前不会销售Nexletol®(贝前列酸)和Nexlizet®(贝前列酸和依折麦布)的仿制药版本。
Esperion Therapeutics Inc.宣布与Anda Filer和DR. Reddy's Laboratories达成和解协议。根据协议条款,这两家公司承诺在2040年4月19日之前不会销售Nexletol®(贝前列酸)和Nexlizet®(贝前列酸和依折麦布)的仿制药版本。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.